RPG Life Sciences Ltd (RPGLIFE) — Announcement | 9 September 2026

· BSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
RPGAP allotted 40% equity to ILSF and VJF for INR 243.33 crores
🔄 What Changed
Equity share capital of RPGAP increased by 40% through new allotment
💡 Investor Takeaway
This investment solidifies RPGAP's strategic position and may drive future pharma growth.

RPG Life Sciences announced that its subsidiary RPGAP allotted shares to ILSF and VJF for INR 243.33 crores, representing 40% of RPGAP's equity, strengthening its ownership structure and signaling strategic investment in pharma growth.

📄 View Original Announcement (PDF)

About RPG Life Sciences Ltd (RPGLIFE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹4,456.85 Cr P/E: 37.3 ROE: 19.8% ROCE: 25.8% Div Yield: 0.89%

View full RPGLIFE stock details →

📡 Get AI alerts when RPGLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RPGLIFE — Free

📊 More RPGLIFE filings

See all RPGLIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when RPGLIFE files new disclosures

Track RPGLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RPGLIFE — Free

Free account · 2 AI queries/day